Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use DisorderUnknown journal · 2026-05-011080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-30Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy onesPsychiatry Research · 2026-02-12Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-08Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-03Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRIJournal of Cerebral Blood Flow & Metabolism · 2024-11-28Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Pilot and Feasibility Studies · 2023-10-04Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal surveyFrontiers in Psychiatry · 2023-09-18Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-06Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.ACS Chemical Neuroscience · 2022-08-23Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-07-01Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain · 2022-03-31Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of Psychopharmacology · 2022-01-31Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in Neuroergonomics · 2022-01-19Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of Psychopharmacology · 2021-02-19Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Effects of Psilocybin-Assisted Therapy on Major Depressive DisorderJAMA Psychiatry · 2020-11-03Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attentionNeuroImage · 2020-05-22Emotions and brain function are altered up to one month after a single high dose of psilocybinScientific Reports · 2020-02-09Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-07-29"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and Cannabinoid Research · 2018-02-28Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in Psychology · 2017-07-24Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and Individual Differences · 2017-06-06Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-20The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of Psychopharmacology · 2016-11-16Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-10-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.Science & Justice · 2006-03-31